Datos clínicos pacientes COVID-19, desde 2018 (prepandemia) hasta 2022 (pandemia)

Registro completo

Título

Datos clínicos pacientes COVID-19, desde 2018 (prepandemia) hasta 2022 (pandemia)

Autor(es)

Repossi Marquez, Pablo Gaston

Afiliación(es) del/de los autor(es)

Repossi Marquez, Pablo Gaston. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones en Ciencias de la Salud. Universidad Nacional de Córdoba. Instituto de Investigaciones en Ciencias de la Salud; Argentina

Resumen

Antecedents: Older adults were the segment of the population most affected by the COVID-19 pandemic. Type 2 diabetes (DBT2) also has a high prevalence in this age group, and its preexistence increases susceptibility, severity, and mortality from COVID-19. The objectives of this work were to calculate and compare the main epidemiological variables, between groups with DBT2 and without DBT2 in the study population, before and during the COVID-19 pandemic. Aim: To determine if there is an association of higher mortality from COVID-19 with the presence of DBT2 in this population of older adults. Methodology: Retrospective observational study (2018-2022) of medical records (n=1020) of older adults (≥65 years) treated at the "San Ricardo Pampuri" Center in Villa Carlos Paz, Córdoba, Argentina. They were statistically analyzed by ANOVA test for quantitative data and Chi-square for categorical data using Infostat (α=0.05). The ethical norms of confidentiality and anonymity were respected. Results: •Population data: Gender distribution=62% male/38% female. 47% of the population suffered from DBT2. Total COVID-19 prevalence: 46% of the population (469 cases) during the study period. •COVID-19 incidences (%, DBT2 and non-DBT2 patients respectively): 2020: 25.15 vs 15.78; 2021: 22.95 vs. 14.73; 2022: 11.26 vs. 5.38. •COVID-19 mortality (%): Total Average=0.63; in DBT2= 1.00 vs. No DBT2=0.32. 72% of the deceased had DBT2. Annual mortality and fatalities from COVID-19 were higher for those with DBT2. In 2020 and 2021 COVID-19 was the leading cause of death in the population studied. •Excess Mortality: Average General Mortality (%) pre-pandemic (2018-2019)=1.86 vs pandemic (2020-2022)=2.72 (46% increase). •Average age of death from COVID-19: DBT2=76.4; Not DBT2=84.1. •Vaccination: 83% of deceased diabetic patients (2020-2022) were not vaccinated against SARS-COV-2. In 2022, coverage of more than 80% of the population was achieved with vaccines (≥ 2 doses) against SARS-COV-2. Conclusion: The COVID-19 pandemic had a negative impact on the population parameters studied, with these increases being greater in the group with DBT2. An increased mortality risk for COVID-19 was observed in patients with T2DM. In 2022, there was a large decrease in incidence, mortality, and lethality (general and specific for COVID-19) compared to 2021. The improvement of the variables recorded in 2022 can be associated with the great coverage achieved in vaccination campaigns.

Año de publicación

2024

Idioma

español

Formato (Tipo MIME)

application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

Clasificación temática de acuerdo a la FORD

Medicina clínica

Condiciones de uso

Parcialmente restringido. Para acceder a los datos contactate con el repostiorio. Protección de datos personales (Ley 25.326)

Repositorio digital

CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas